Tue. 14 May 2024, 4:06pm ET
Benzinga
Earnings, Earnings Misses, News
TRACON Pharma (NASDAQ:TCON) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(1.19) by 11.76 percent. This is a 269.44 percent decrease over losses of $(0.36) per share from the same period last year. The company reported $100.00 thousand in sales this quarter.